T‐cell activation by transgenic rice seeds expressing the genetically modified Japanese cedar pollen allergens
Open Access
- 19 July 2019
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 158 (2) , 94-103
Abstract
Summary: Transgenic rice seeds that contain genetically modified Cry j 1 and Cry j 2, the two major allergens of Cryptomeria japonica (Japanese cedar; JC), have been developed as immunotherapeutic candidates for JC pollinosis. Because the transgenic rice (TG‐rice) seeds express allergens containing whole amino acid sequences of Cry j 1 and Cry j 2 in the endosperm tissue (edible part of rice grain), they can potentially target all Cry j 1‐ and Cry j 2‐specific T‐cells. However, it was unknown whether antigenicity of Cry j 1 and Cry j 2 could be completely preserved in TG‐rice seeds. We verified the antigenicity of TG‐rice seeds to T‐cells through the analysis of the proliferative responses of T‐cells in Cry j 1‐ or Cry j 2‐immunized mice or T‐cell lines to TG‐rice seed extract. First, four mouse strains were immunized with Cry j 1 or Cry j 2. T‐cells in the immunized mice proliferated on treatment with TG‐rice seed extract, but not non‐transgenic wild‐type rice (WT‐rice) seed extract. Furthermore, T‐cell lines were established from the spleen cells of the immunized mice. Each T‐cell line resulted in a proliferative response to TG‐rice seed extract, but not to WT‐rice seed extract, suggesting that TG‐rice seeds certainly express T‐cell epitopes corresponding to T‐cell lines. Considering the modified amino acid sequences of Cry j 1 and Cry j 2 in TG‐rice seeds, the expression of specific T‐cell epitopes suggested that TG‐rice seeds express all possible T‐cell epitope repertoires of Cry j 1 and Cry j 2.Keywords
This publication has 23 references indexed in Scilit:
- Sublingual (SLIT) Versus Oral Immunotherapy (OIT) for Food AllergyCurrent Allergy and Asthma Reports, 2014
- Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosisPlant Biotechnology Journal, 2012
- The safety and efficacy of sublingual and oral immunotherapy for milk allergyJournal of Allergy and Clinical Immunology, 2012
- Recognition of T Cell Epitopes Unique to Cha o 2, the Major Allergen in Japanese Cypress Pollen, in Allergic Patients Cross-Reactive to Japanese Cedar and Japanese Cypress PollenAllergology International, 2009
- Present Situation of Cedar Pollinosis in Japan and its Immune ResponsesAllergology International, 2009
- Analysis of Helper T Cell Responses to Cry j 1-Derived Peptides in Patients with Nasal Allergy: Candidate for Peptide-Based Immunotherapy of Japanese Cedar PollinosisAllergology International, 2009
- Identification of human T cell epitopes in Japanese cypress pollen allergen, Cha o 1, elucidates the intrinsic mechanism of cross‐allergenicity between Cha o 1 and Cry j 1, the major allergen of Japanese cedar pollen, at the T cell levelClinical & Experimental Allergy, 2005
- Common antigenicity between Japanese cedar (Cryptomeria japonica) pollen and Japanese cypress (Chamaecyparis obtusa) pollen, II. Determination of the cross‐reacting T‐cell epitope of Cry j 1 and Cha o 1 in miceImmunology, 2000
- Single amino acid substitutions on a Japanese cedar pollen allergen (Cry j 1)-derived peptide induced alterations in human T cell responses and T cell receptor antagonismJournal of Allergy and Clinical Immunology, 1996
- Sensitivity to two major allergens (Cry j I and Cry j II) in patients with Japanese cedar (Cryptomeria japonica) pollinosisClinical & Experimental Allergy, 1995